Skip to Main Content
Skip Nav Destination

Elexacaftor-Tezacaftor-Ivacaftor: The First Triple-Combination Cystic Fibrosis Transmembrane Conductance Regulator Modulating Therapy

The Journal of Pediatric Pharmacology and Therapeutics (2020) 25 (3): 192–197.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal